About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Il22tm1.1Lex
targeted mutation 1.1, Lexicon Genetics
MGI:3699310
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Il22tm1.1Lex/Il22tm1.1Lex involves: 129S5/SvEvBrd MGI:4459521
hm2
 		Il22tm1.1Lex/Il22tm1.1Lex involves: 129S5/SvEvBrd * C57BL/6 MGI:3700050
cn3
 		Il22tm1.1Lex/Il22tm1.1Lex
Riok2tm1c(KOMP)Wtsi/Riok2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+ 		involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca MGI:6712732
cx4
 		Il22tm1.1Lex/Il22tm1.1Lex
Commd10Tg(Vav1-icre)A2Kio/Commd10+ 		involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca MGI:6712736


Genotype
MGI:4459521
hm1
Allelic
Composition		 Il22tm1.1Lex/Il22tm1.1Lex
Genetic
Background		 involves: 129S5/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il22tm1.1Lex mutation (2 available); any Il22 mutation (29 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
increased susceptibility to bacterial infection induced morbidity/mortality ( J:161073 )
• ranged from 80% to 100% in the second week after infection with C. rodentium

immune system
colitis ( J:161073 )
• an increase in submucosal and transmural inflammation after r C. rodentium infection
abnormal circulating cytokine level ( J:179011 )
• reduced levels of CCL3 and CCL4 after Aspergillus fumigatus infection
decreased circulating interleukin-1 alpha level ( J:179011 )
• after Aspergillus fumigatus infection
decreased circulating interleukin-12 level ( J:179011 )
• after Aspergillus fumigatus infection
decreased circulating interleukin-12b level ( J:179011 )
• after Aspergillus fumigatus infection
increased circulating interleukin-17 level ( J:179011 )
• elevated IL-17A after Aspergillus fumigatus infection
decreased circulating tumor necrosis factor level ( J:179011 )
• after Aspergillus fumigatus infection
lung inflammation ( J:179011 )
• develop an 8 fold higher Aspergillus fumigatus burden by 24 hours after Aspergillus fumigatus infection
increased susceptibility to bacterial infection induced morbidity/mortality ( J:161073 )
• ranged from 80% to 100% in the second week after infection with C. rodentium
increased susceptibility to fungal infection ( J:179011 )
• develop an 8 fold higher Aspergillus fumigatus burden by 24 hours after Aspergillus fumigatus infection

growth/size/body
decreased body weight ( J:161073 )
• continue to lose weight after C. rodentium infection

digestive/alimentary system
abnormal large intestine crypts of Lieberkuhn morphology ( J:161073 )
• bacteria penetrate deeply into the colonic crypts after C. rodentium infection
abnormal colon morphology ( J:161073 )
• an increase in mucosal hyperplasia and multiple foci of colonic mucosal ulceration after r C. rodentium infection
colitis ( J:161073 )
• an increase in submucosal and transmural inflammation after r C. rodentium infection

endocrine/exocrine glands
abnormal large intestine crypts of Lieberkuhn morphology ( J:161073 )
• bacteria penetrate deeply into the colonic crypts after C. rodentium infection

liver/biliary system
multifocal hepatic necrosis ( J:161073 )
• with embolic microabscessation in the liver following C. rodentium infection

respiratory system
lung inflammation ( J:179011 )
• develop an 8 fold higher Aspergillus fumigatus burden by 24 hours after Aspergillus fumigatus infection

homeostasis/metabolism
abnormal circulating cytokine level ( J:179011 )
• reduced levels of CCL3 and CCL4 after Aspergillus fumigatus infection
decreased circulating interleukin-1 alpha level ( J:179011 )
• after Aspergillus fumigatus infection
decreased circulating interleukin-12 level ( J:179011 )
• after Aspergillus fumigatus infection
decreased circulating interleukin-12b level ( J:179011 )
• after Aspergillus fumigatus infection
increased circulating interleukin-17 level ( J:179011 )
• elevated IL-17A after Aspergillus fumigatus infection
decreased circulating tumor necrosis factor level ( J:179011 )
• after Aspergillus fumigatus infection




Genotype
MGI:3700050
hm2
Allelic
Composition		 Il22tm1.1Lex/Il22tm1.1Lex
Genetic
Background		 involves: 129S5/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Il22tm1.1Lex mutation (2 available); any Il22 mutation (29 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
ear inflammation ( J:118261 )
• Il-23 induced ear swelling is significantly reduced after Il-23 treatment compared to wild-type
• after Il-23 treatment, mutants have reduced neutrophilic infiltration
abnormal cytokine secretion ( J:118261 )
• Il-22 production is almost absent compared to wild-type

hearing/vestibular/ear
ear inflammation ( J:118261 )
• Il-23 induced ear swelling is significantly reduced after Il-23 treatment compared to wild-type
• after Il-23 treatment, mutants have reduced neutrophilic infiltration

integument
mixed cellular infiltration to dermis ( J:118261 )
• minimal degree of dermal inflammation is observed compared to PBS-treated wild-type mice
thick dermal layer ( J:118261 )
• some dermal hyperplasia is observed compared to PBS-treated wild-type mice
acanthosis ( J:118261 )
• epidermal acanthosis is significantly decreased after Il-23 treatment compared to wild-type




Genotype
MGI:6712732
cn3
Allelic
Composition		 Il22tm1.1Lex/Il22tm1.1Lex
Riok2tm1c(KOMP)Wtsi/Riok2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
Genetic
Background		 involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Commd10Tg(Vav1-icre)A2Kio mutation (3 available); any Commd10 mutation (24 available)
Il22tm1.1Lex mutation (2 available); any Il22 mutation (29 available)
Riok2tm1c(KOMP)Wtsi mutation (0 available); any Riok2 mutation (33 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
increased erythroid progenitor cell number ( J:305794 )
• mice show an increase in RII and RIV erythroid precursors compared to IL-22-sufficient Riok2-haploinsufficent mice on day 7 after treatments with phenylhydrazine
increased erythrocyte cell number ( J:305794 )
• mice exhibit increased numbers of peripheral blood red blood cells compared to IL-22-sufficient Riok2-haploinsufficent mice on day 7 after treatments with phenylhydrazine to induce acute hemolytic stress

homeostasis/metabolism
decreased physiological sensitivity to xenobiotic ( J:305794 )
• mice show alleviation of the stress-induced (via phenylhydrazine treatment) anemia seen in IL-22-sufficient Riok2-haploinsufficent mice




Genotype
MGI:6712736
cx4
Allelic
Composition		 Il22tm1.1Lex/Il22tm1.1Lex
Commd10Tg(Vav1-icre)A2Kio/Commd10+
Genetic
Background		 involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Commd10Tg(Vav1-icre)A2Kio mutation (3 available); any Commd10 mutation (24 available)
Il22tm1.1Lex mutation (2 available); any Il22 mutation (29 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
increased erythrocyte cell number ( J:305794 )
• mice show an increase in peripheral red blood cells after treatment with phenylhydrazine to induce acute hemolytic stress

homeostasis/metabolism
decreased physiological sensitivity to xenobiotic ( J:305794 )
• mice show an increase in peripheral red blood cells after treatment with phenylhydrazine to induce acute hemolytic stress




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory